Glycyrrhizin Blocks the Detrimental Effects of HMGB1 on Cortical Neurogenesis After Traumatic Neuronal Injury
- PMID: 33096930
- PMCID: PMC7593920
- DOI: 10.3390/brainsci10100760
Glycyrrhizin Blocks the Detrimental Effects of HMGB1 on Cortical Neurogenesis After Traumatic Neuronal Injury
Abstract
Despite medical advances, neurological recovery after severe traumatic brain injury (TBI) remains poor. Elevated levels of high mobility group box protein-1 (HMGB1) are associated with poor outcomes; likely via interaction with receptors for advanced-glycation-end-products (RAGE). We examined the hypothesis that HMGB1 post-TBI is anti-neurogenic and whether this is pharmacologically reversible. Post-natal rat cortical mixed neuro-glial cell cultures were subjected to needle-scratch injury and examined for HMGB1-activation/neuroinflammation. HMGB1-related genes/networks were examined using genome-wide RNA-seq studies in cortical perilesional tissue samples from adult mice. Post-natal rat cortical neural stem/progenitor cell cultures were generated to quantify effects of injury-condition medium (ICM) on neurogenesis with/without RAGE antagonist glycyrrhizin. Needle-injury upregulated TNF-α/NOS-2 mRNA-expressions at 6 h, increased proportions of activated microglia, and caused neuronal loss at 24 h. Transcriptome analysis revealed activation of HMGB1 pathway genes/canonical pathways in vivo at 24 h. A 50% increase in HMGB1 protein expression, and nuclear-to-cytoplasmic translocation of HMGB1 in neurons and microglia at 24 h post-injury was demonstrated in vitro. ICM reduced total numbers/proportions of neuronal cells, but reversed by 0.5 μM glycyrrhizin. HMGB1 is activated following in vivo post mechanical injury, and glycyrrhizin alleviates detrimental effects of ICM on cortical neurogenesis. Our findings highlight glycyrrhizin as a potential therapeutic agent post-TBI.
Keywords: HMGB1; neurogenesis; neuroinflammation; traumatic brain injury.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
Neurogenesis after traumatic brain injury - The complex role of HMGB1 and neuroinflammation.Neuropharmacology. 2021 Feb 1;183:108400. doi: 10.1016/j.neuropharm.2020.108400. Epub 2020 Nov 13. Neuropharmacology. 2021. PMID: 33189765 Review.
-
Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.J Neuroinflammation. 2017 Jul 24;14(1):143. doi: 10.1186/s12974-017-0917-3. J Neuroinflammation. 2017. PMID: 28738820 Free PMC article.
-
Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences.Exp Neurol. 2019 Oct;320:112979. doi: 10.1016/j.expneurol.2019.112979. Epub 2019 Jun 21. Exp Neurol. 2019. PMID: 31229637
-
Minocycline Attenuates High Mobility Group Box 1 Translocation, Microglial Activation, and Thalamic Neurodegeneration after Traumatic Brain Injury in Post-Natal Day 17 Rats.J Neurotrauma. 2018 Jan 1;35(1):130-138. doi: 10.1089/neu.2017.5093. Epub 2017 Aug 22. J Neurotrauma. 2018. PMID: 28699371 Free PMC article.
-
The Role of HMGB1 in Traumatic Brain Injury-Bridging the Gap Between the Laboratory and Clinical Studies.Curr Neurol Neurosci Rep. 2021 Dec 6;21(12):75. doi: 10.1007/s11910-021-01158-3. Curr Neurol Neurosci Rep. 2021. PMID: 34870759 Review.
Cited by
-
HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target.Front Neurol. 2022 Oct 31;13:1029891. doi: 10.3389/fneur.2022.1029891. eCollection 2022. Front Neurol. 2022. PMID: 36388178 Free PMC article. Review.
-
Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway.Front Mol Neurosci. 2022 Sep 16;15:1013033. doi: 10.3389/fnmol.2022.1013033. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36187352 Free PMC article. Review.
-
High mobility group box protein 1 and white matter injury following traumatic brain injury: perspectives on mechanisms and therapeutic strategies.Neural Regen Res. 2022 Aug;17(8):1739-1740. doi: 10.4103/1673-5374.332135. Neural Regen Res. 2022. PMID: 35017426 Free PMC article. No abstract available.
-
Disulfide HMGB1 acts via TLR2/4 receptors to reduce the numbers of oligodendrocyte progenitor cells after traumatic injury in vitro.Sci Rep. 2021 Mar 17;11(1):6181. doi: 10.1038/s41598-021-84932-0. Sci Rep. 2021. PMID: 33731757 Free PMC article.
References
-
- Prevalence and most common causes of disability among adults–United States, 2005. Mmwr. Morb. Mortal. Wkly. Rep. 2009;58:421–426. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
